<DOC>
	<DOCNO>NCT00005983</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy use high-energy x-rays damage tumor cell . It yet know whether mastectomy , chemotherapy , and/or hormone therapy effective without radiation therapy treat breast cancer . PURPOSE : Randomized phase III trial compare effectiveness mastectomy , chemotherapy , and/or hormone therapy without radiation therapy treat woman stage II breast cancer .</brief_summary>
	<brief_title>S9927 Radiation Therapy After Surgery , Chemotherapy , and/or Hormone Therapy Stage II Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Compare overall disease-free survival woman stage II breast cancer one three positive node treat radiotherapy v observation mastectomy adjuvant chemotherapy and/or hormonal therapy . - Compare local regional control patient treat regimen . - Assess potential toxic effect radiotherapy patient population . OUTLINE : This randomize , multicenter study . Patients stratify accord prior systemic hormonal therapy ( chemotherapy without hormonal therapy v hormonal therapy alone ) , prior taxane exposure ( yes v ) , duration chemotherapy ( chemotherapy v le 3 month v 3-5 month v 6 month ) . Patients randomize one two treatment arm . - Arm I : Patients undergo radiotherapy 5 day week 5 week . - Arm II : Patients observe disease progression . Patients follow every 6 month 2 year annually 15 year . PROJECTED ACCRUAL : A total 2,500 patient ( 1,250 per treatment arm ) accrue study within 5 year .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage II adenocarcinoma breast ( T12 , N1 , M0 ) Primary tumor great 5 cm At least 1 3 positive axillary lymph node Nodes positive solely cytokeratin stain No apocrine , adenocystic , squamous cell carcinoma sarcomas breast No bilateral breast cancer No active local regional disease Must undergone modify radical mastectomy level I II without level III axillary dissection ( least 10 node examine ) within past 8 month Surgical margin negative invasive noninvasive ductal carcinoma No gross extracapsular disease residual disease axilla Microscopic extracapsular extension allow No mastectomy local failure follow lumpectomy Must receive adjuvant chemotherapy and/or hormonal therapy mastectomy Hormone receptor status : Not specify PATIENT CHARACTERISTICS : Age : 21 Sex : Female Menopausal status : Pre postmenopausal Performance status : Zubrod 01 Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : Not pregnant nursing Fertile patient must use effective contraception No prior malignancy within past 5 year except adequately treat basal cell squamous cell skin cancer carcinoma situ cervix No serious medical psychiatric illness would preclude study compliance PRIOR CONCURRENT THERAPY : Biologic therapy : No prior trastuzumab ( Herceptin ) Chemotherapy : See Disease Characteristics No 6 week since prior adjuvant chemotherapy No prior chemotherapy Concurrent adjuvant chemotherapy allow Endocrine therapy : See Disease Characteristics Concurrent adjuvant hormonal therapy allow Radiotherapy : No prior chest wall nodal radiotherapy Surgery : See Disease Characteristics Breast reconstruction allow Other : Concurrent registration another adjuvant chemotherapy hormonal therapy study allow</criteria>
	<gender>Female</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>stage II breast cancer</keyword>
</DOC>